Commentary - (2025) Volume 16, Issue 3
Received: 02-Jun-2025, Manuscript No. jtse-26-184756;
Editor assigned: 04-Jun-2025, Pre QC No. P-184756;
Reviewed: 18-Jun-2025, QC No. Q-184756;
Revised: 23-Jun-2025, Manuscript No. R-184756;
Published:
30-Jun-2025
, DOI: 10.37421/2157-7552.2025.16.436
Citation: Suzuki, Hana. ”Immune System’s Role in Tissue Engineering and Regeneration.” J Tissue Sci Eng 16 (2025):436.
Copyright: © 2025 Suzuki H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
The field of tissue engineering is undergoing a significant transformation driven by a deeper understanding and manipulation of the immune system. Traditionally viewed as a barrier to successful implantation, the immune system is now recognized as a crucial regulator of tissue regeneration and integration. By deliberately altering the immune response, researchers are uncovering novel strategies to enhance the efficacy of engineered tissues and regenerative medicine applications. This approach, known as immunomodulation, involves strategically guiding immune cell behavior and signaling pathways to promote a more favorable environment for tissue repair and reconstruction. The deliberate alteration of the immune system's response, or immunomodulation, is revolutionizing tissue engineering. By controlling inflammation and promoting beneficial immune cell interactions, researchers are enhancing the integration and function of engineered tissues. Key strategies include using biomaterials that actively guide immune responses and designing cellular therapies to modulate local immunity, ultimately improving outcomes for regenerative medicine applications [1].
Macrophages play a critical role in how the body responds to implanted biomaterials, a phenomenon known as the foreign body response. Understanding and manipulating macrophage polarizationâ??shifting them from pro-inflammatory to pro-regenerative phenotypesâ??is a crucial strategy to prevent fibrotic encapsulation and promote successful tissue integration. This highlights how material design can directly influence immune cell behavior to achieve better therapeutic results [2].
Immunomodulatory hydrogels are being investigated for their ability to control the inflammatory environment during cartilage tissue engineering. By incorporating specific signaling molecules, these hydrogels can suppress acute inflammation and recruit cells that promote chondrogenesis. Tailoring the immune milieu within the scaffold significantly improves the quality and mechanical properties of engineered cartilage constructs [3].
Mesenchymal stem cell (MSC)-derived exosomes are emerging as potent immunomodulatory agents in tissue engineering. These exosomes can deliver bioactive cargo that suppresses immune overreactions and promotes tissue repair. This cell-free strategy harnesses the regenerative and immunomodulatory power of MSCs, making them attractive for various tissue engineering applications [4].
Engineered immune cells, specifically T regulatory cells (Tregs), are being developed to modulate immune responses in organ transplantation and tissue engineering. Enhancing Treg function or number aims to induce immune tolerance towards the engineered graft, reducing the need for systemic immunosuppression and improving graft survival and integration [5].
Biomimetic scaffolds are being designed to actively interact with immune cells and promote vascularization in engineered tissues. By mimicking the extracellular matrix and presenting specific immune-modulatory signals, these scaffolds can guide inflammatory cells to secrete pro-angiogenic factors, leading to improved blood supply and tissue survival [6].
Targeting specific immune checkpoints, akin to strategies used in cancer immunotherapy, is being explored to enhance the success of tissue engineering implants. Blocking inhibitory signals or enhancing activating signals can create a more permissive environment for graft integration and reduce immune rejection, offering new avenues for immunomodulation in regenerative medicine [7].
The role of inflammasomes, multi-protein complexes regulating inflammatory responses, is being examined in tissue engineering. Modulating inflammasome activity can control excessive inflammation that leads to tissue damage and fibrosis, thereby promoting a more regenerative environment. Strategies for inflammasome inhibition in engineered tissues are under investigation [8].
Microfluidic devices are being employed to create controlled inflammatory microenvironments for testing the immunomodulatory effects of novel biomaterials. Precise control over cell-material interactions and immune cell infiltration allows for high-throughput screening of materials designed to elicit specific immune responses, accelerating the development of immunomodulatory tissue engineering scaffolds [9].
Local immune cells, such as dendritic cells and neutrophils, significantly influence the success of engineered cardiac patches. Modulating these cells' functions, for instance, by reducing their pro-inflammatory activation or promoting inflammation resolution, is crucial for preventing scar formation and encouraging functional myocardial tissue regeneration. This emphasizes the importance of targeted immune cell manipulation for improved cardiac repair [10].
Immunomodulation, the deliberate alteration of the immune system's response, is a transformative concept in tissue engineering, moving beyond viewing immunity solely as a hurdle to successful implantation. This strategy leverages the immune system's inherent capacity for repair and regeneration by controlling inflammatory processes and fostering beneficial immune cell interactions. By employing biomaterials that actively direct immune responses and developing cellular therapies designed to modulate local immunity, researchers are achieving significant enhancements in the integration and functionality of engineered tissues, paving the way for improved outcomes in regenerative medicine [1].
Within the complex landscape of biomaterial-host interactions in tissue engineering, macrophages play a pivotal role, particularly in the foreign body response. A key strategy involves manipulating macrophage polarization, guiding these cells from a pro-inflammatory state to a pro-regenerative phenotype. This shift is essential for circumventing fibrotic encapsulation, a common impediment to successful tissue integration, and underscores the impact of biomaterial design on dictating immune cell behavior for optimized therapeutic results [2].
In the realm of cartilage tissue engineering, immunomodulatory hydrogels are proving instrumental in managing the inflammatory milieu. These advanced materials incorporate specific signaling molecules that can effectively dampen acute inflammation and recruit cells vital for chondrogenesis. The research demonstrates that by precisely tailoring the immunological environment within the scaffold, the quality and mechanical integrity of engineered cartilage constructs can be substantially improved [3].
Mesenchymal stem cells (MSCs) offer a promising avenue for immunomodulation through their secreted exosomes. These nanoscale vesicles carry bioactive cargo capable of suppressing excessive immune reactions and promoting tissue repair. This cell-free approach allows for the harnessing of MSCs' regenerative and immunomodulatory properties without the complexities of cell transplantation, making it an attractive option for diverse tissue engineering applications [4].
The engineering of specific immune cell populations, most notably T regulatory cells (Tregs), is a sophisticated strategy for modulating immune responses in critical contexts like organ transplantation and tissue engineering. The goal is to augment Treg function or numbers to induce immune tolerance towards the engineered graft. This approach aims to minimize reliance on systemic immunosuppression, thereby enhancing graft survival and integration [5].
Biomimetic scaffolds are being ingeniously designed to not only mimic the natural extracellular matrix but also to actively engage with immune cells in a manner that promotes vascularization within engineered tissues. By presenting precisely tuned immunomodulatory signals, these scaffolds can guide inflammatory cells to release pro-angiogenic factors, which are critical for establishing adequate blood supply and ensuring the viability of the engineered tissue [6].
A novel strategy emerging from cancer immunotherapy research involves targeting immune checkpoints to improve the success rates of tissue engineering implants. By either inhibiting suppressive immune signals or enhancing activating signals, a more permissive microenvironment can be established for graft integration. This approach has the potential to significantly reduce immune rejection and advance immunomodulation in regenerative medicine [7].
Inflammasomes, which are multi-protein complexes that govern inflammatory responses, are increasingly recognized for their impact on tissue engineering outcomes. Strategies aimed at modulating inflammasome activity can effectively control detrimental inflammatory processes that lead to tissue damage and fibrosis, thus fostering a more conducive environment for regeneration. Research is exploring various methods for inhibiting inflammasome activity within engineered tissues [8].
Microfluidic devices offer an advanced platform for creating highly controlled inflammatory microenvironments, which is invaluable for assessing the immunomodulatory properties of novel biomaterials. The ability to precisely manage cell-material interactions and immune cell infiltration in these devices facilitates high-throughput screening of materials engineered to elicit specific immune responses, thereby accelerating the development cycle for immunomodulatory tissue engineering scaffolds [9].
The functional success of engineered cardiac patches is significantly influenced by local immune cells, including dendritic cells and neutrophils. Modulating the behavior of these cells, for example, by dampening their pro-inflammatory tendencies or encouraging the resolution of inflammation, is paramount for preventing scar tissue formation and promoting the regeneration of functional myocardial tissue. This research highlights the critical importance of targeted immune cell manipulation in achieving superior cardiac repair outcomes [10].
This collection of research underscores the critical role of the immune system in tissue engineering and regenerative medicine. Strategies are being developed to modulate immune responses, moving beyond viewing immunity as a barrier to successful tissue integration. Key approaches include manipulating macrophage polarization, utilizing immunomodulatory hydrogels, and employing mesenchymal stem cell-derived exosomes. Engineered immune cells like T regulatory cells are being explored to induce immune tolerance. Furthermore, biomimetic scaffolds and immune checkpoint inhibition are being investigated to create favorable environments for tissue regeneration. Microfluidic platforms are enabling the high-throughput screening of immunomodulatory biomaterials, while targeted modulation of local immune cells is crucial for specific applications like cardiac repair. Overall, the research highlights a paradigm shift towards harnessing and directing the immune system for enhanced therapeutic outcomes.
None
None
Journal of Tissue Science and Engineering received 807 citations as per Google Scholar report
